Detalles de la búsqueda
1.
The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records.
BMC Med
; 22(1): 211, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38807170
2.
The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.
Diabetologia
; 66(2): 300-309, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411396
3.
Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy.
Cardiovasc Diabetol
; 22(1): 302, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919773
4.
Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a favourable metabolic profile.
Diabet Med
; 38(9): e14531, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33501652
5.
Reconfigurable T-junction DNA Origami.
Angew Chem Int Ed Engl
; 59(37): 15942-15946, 2020 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524699
6.
HbA1c screening for the diagnosis of diabetes. Reply to Broz J, Brabec M, Krollová P et al [letter].
Diabetologia
; 66(8): 1578-1579, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37272950
7.
Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.
Diabetologia
; 66(8): 1585, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212888
8.
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study.
BMJ Open
; 14(1): e078135, 2024 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296292
9.
Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches.
J Clin Epidemiol
; 153: 34-44, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368478
10.
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review.
Commun Med (Lond)
; 3(1): 131, 2023 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37794166
11.
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors.
medRxiv
; 2023 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37131814
12.
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study.
Lancet Digit Health
; 4(12): e873-e883, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36427949
13.
Challenges of detecting childhood diabetes in primary care.
Lancet Digit Health
; 6(6): e375-e376, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38789136
14.
Corrigendum to 'Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches' [Journal of Clinical Epidemiology (2023) 34-44].
J Clin Epidemiol
; 159: 356, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316353
15.
Glycated haemoglobin measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and routine clinical care.
Int J Epidemiol
; 51(3): 1022-1024, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026015
Resultados
1 -
15
de 15
1
Próxima >
>>